• Clinical Technology
  • Adult Immunization
  • Hepatology
  • Pediatric Immunization
  • Screening
  • Psychiatry
  • Allergy
  • Women's Health
  • Cardiology
  • Pediatrics
  • Dermatology
  • Endocrinology
  • Pain Management
  • Gastroenterology
  • Geriatrics
  • Infectious Disease
  • Obesity Medicine
  • Rheumatology
  • Oncology
  • Nephrology
  • Neurology
  • Pulmonology

Substance Use and Abuse: An Update

Slideshow

Brief summaries highlight the latest developments and research findings regarding this serious and growing health problem.

Related Videos
"Vaccination is More of a Marathon than a Sprint"
Vaccines are for Kids, Booster Fatigue, and Other Obstacles to Adult Immunization
Related Content
First-Ever Guideline Establishes Lifestyle Intervention as Central Strategy in Treating and Reversing Type 2 Diabetes and Prediabetes / image credit ©American College of Lifestyle Medicine

First-Ever Guideline Establishes Lifestyle Intervention as Central Strategy in Treating and Reversing Type 2 Diabetes and Prediabetes

Grace Halsey
June 11th 2025
Article

The Weekly Dose: Advancements in Colonoscopy, AI for Mammography, and Telemedicine Antibiotic Stewardship

The Weekly Dose: Advancements in Colonoscopy, AI for Mammography, and Telemedicine Antibiotic Stewardship

Sydney Jennings
June 4th 2025
Podcast

Discover the latest breakthroughs in clinical research, from at-home cancer screening to AI advancements in mammography, shaping future healthcare practices.

Lebrikizumab Demonstrates Efficacy, Safety in Patients With Skin of Color With AD

Lebrikizumab Demonstrates Efficacy, Safety in Patients With Skin of Color With AD

Sydney Jennings
June 11th 2025
Article

RAD 2025. Lebrikizumab improved skin clearance, itch, and pigmentation in patients with skin of color and atopic dermatitis, with strong safety data through 24 weeks, according to late-breaking data.

The Weekly Dose: How Medicaid Policies Impact Postpartum Depression Care

The Weekly Dose: How Medicaid Policies Impact Postpartum Depression Care

Sydney Jennings;Elizabeth Mollard, PhD
May 22nd 2025
Podcast

At ACOG 2025, Elizabeth Mollard, PhD, discussed her research on Medicaid PPD screening and coverage policies on PPD diagnosis.

Arcutis Begins Study of Roflumilast Cream 0.05% in Infants with Atopic Dermatitis / Image credit: ©Юля Шевцова/AdobeStock

Arcutis Begins Study of Roflumilast Cream 0.05% in Infants with Atopic Dermatitis

Sydney Jennings
June 10th 2025
Article

Arcutis Biotherapeutics announced today the enrollment of the first patient in the phase 2 INTEGUMENT-INFANT trial.

George Medicines Announces FDA Approval of Polypill for Treatment of Hypertension in Adults

George Medicines Announces FDA Approval of Polypill for Treatment of Hypertension in Adults

Grace Halsey
June 10th 2025
Article

The novel triple fixed-dose combination of telmisartan, amlodipine and indapamide, is the first of its kind approved for initial treatment of hypertension.

© 2025 MJH Life Sciences

All rights reserved.